2023 annual financial data
Sinovac Biotech 2023 Net margin
Direct answer
Net margin was -22.29%.
Operating income was -546,724,000 USD and net income was -99,918,000 USD.
Operating cash flow was 106,018,000 USD.
Get free Sinovac Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 448,269,000 USD
- Operating income
- -546,724,000 USD
- Net income
- -99,918,000 USD
- Operating cash flow
- 106,018,000 USD